Please assess the completion status of the following clinical trial:

Trial Title: Investigate the Activity of Endotoxin in Severe Sepsis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* ICU patients with new onset of severe sepsis and septic shock~* Presence of at least 2 of the following conditions (These criteria should have occurred between 12 hours before or 6 hours after the onset of the qualifying first organ dysfunction)~* Fever or hypothermia (body temperature over 38 ℃ or under 36 ℃~* Tachycardia (heart rate \> 90 bpm)~* Tachypnea (respiratory rate over 20 breaths/min or under mechanical ventilation)~* Leukocyte count more than 12,000 cells/mm3, less than 4,000 cells/mm3, or more than 10 % of immature form (band)~Exclusion Criteria:~Patient will be excluded if they~* are under 20 years old or older than 99 years old~* have suffered from severe sepsis or septic shock more than 24 hours~* are pregnant~* were treated with another medicine or device in the trial less than 30 days prior to the admission to this trial~* have received organ transplantation less than 1 years prior to this trial~* are terminally ill, for examples with metastasis, with a life expectancy of less than 30 days (certified by the attending physician)~* have already received other blood cleaning treatments, such as CVVH, HD, HF, and PE upon entry into the trial~* have chosen palliative care and signed Do Not Resuscitate sheet~* non-native speaker

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Severe Sepsis (Type: None): Patient with severe sepsis

Based on this trial design, predict the completion outcome and termination type (if applicable).